{"meta":{"query_hash":"6b8a88705aa2","filters":{"venue":"Journal of Parkinson’s Disease and Alzheimer’s Disease"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6b8a88705aa2","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Parkinson%E2%80%99s+Disease+and+Alzheimer%E2%80%99s+Disease"},"results":[{"id":"W4235606092","doi":"10.13188/2376-922x.1000019","title":"A Pilot Study of Oxaloacetate 100 mg Capsules in Parkinson’s Disease Patients","year":2016,"lang":"en","type":"article","venue":"Journal of Parkinson’s Disease and Alzheimer’s Disease","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Parkinson's disease; Citrate synthase; Medicine; Disease; Internal medicine; Physical therapy; Chemistry; Biochemistry","score_opus":0.04016123861405165,"score_gpt":0.2887082149307219,"score_spread":0.24854697631667025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235606092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661875,0.0006630467,0.000307842,0.0001305533,0.000083647385,0.0015803528,0.0001669369,0.000025671969,0.00042320168],"genre_scores_gemma":[0.99478734,0.00077892345,0.0011021465,0.00034292723,0.00015866604,0.0015989934,0.00028563346,0.000008381323,0.00093702105],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991904,0.00043146516,0.000080863196,0.0001237289,0.000057201752,0.00011633844],"domain_scores_gemma":[0.9984036,0.0004995077,0.00018454214,0.00015541162,0.00014440603,0.00061253016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022401453,0.0009329218,0.0024728712,0.00049516244,0.00072800845,0.00065882114,0.0006508047,0.0013137006,0.00405594],"category_scores_gemma":[0.0019321671,0.0005827142,0.0014230682,0.00044459433,0.000882191,0.0008275486,0.00049826107,0.001701764,0.00072292454],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7415109,0.16203633,0.005911019,0.00075554865,0.0008154033,0.0005253838,0.0006386522,0.0003384415,0.03380472,0.00009264988,0.0005285396,0.05304227],"study_design_scores_gemma":[0.093491875,0.89960355,0.0052453238,0.000010353497,0.0001980367,0.000062772495,0.000056805813,0.00008114243,0.00079377985,0.000029677314,0.00041691482,0.000009706732],"about_ca_topic_score_codex":0.00080821983,"about_ca_topic_score_gemma":0.0011820479,"teacher_disagreement_score":0.00405594,"about_ca_system_score_codex":0.0002963476,"about_ca_system_score_gemma":0.001132623,"threshold_uncertainty_score":0.013568521},"labels":[],"label_agreement":null},{"id":"W4246518131","doi":"10.13188/2376-922x.1000031","title":"Amantadine for the Treatment of Parkinson’s Disease and its Associated Dyskinesias","year":2020,"lang":"en","type":"article","venue":"Journal of Parkinson’s Disease and Alzheimer’s Disease","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Amantadine; Parkinson's disease; Medicine; Dyskinesia; Disease; Psychology; Psychiatry; Pharmacology; Internal medicine","score_opus":0.060165886615906966,"score_gpt":0.3021054857880204,"score_spread":0.2419395991721134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246518131","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044521995,0.89600724,0.0036744766,0.0059140897,0.0016155961,0.00019060516,0.000532684,0.00037547186,0.04716791],"genre_scores_gemma":[0.49267954,0.45133054,0.010719883,0.006827149,0.001895633,0.0003566767,0.0011573266,0.000087914326,0.03494536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998386,0.000051726936,0.000019872548,0.000021645552,0.000050493512,0.000017588582],"domain_scores_gemma":[0.99989593,0.000023283917,0.00002436104,0.0000063897305,0.00002658303,0.000023477996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002828357,0.00030882997,0.00047489183,0.00045837494,0.00027100678,0.00026480985,0.00033186658,0.0007389333,0.0036599752],"category_scores_gemma":[0.00037844054,0.000062898675,0.00045805672,0.0002991916,0.00015398674,0.00024855832,0.00022571399,0.0012068356,0.001840305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00217454,0.0008960064,0.0010519655,0.0036222928,0.00034812966,0.0030416418,0.0001362761,0.00019610532,0.036062256,0.0031620078,0.044535708,0.9047732],"study_design_scores_gemma":[0.0020188051,0.0039579906,0.013238639,0.0016244397,0.00043446047,0.02277662,0.00011407076,0.0006490758,0.017288767,0.0043158648,0.9335241,0.000057154604],"about_ca_topic_score_codex":0.00053318264,"about_ca_topic_score_gemma":0.0016175036,"teacher_disagreement_score":0.0036599752,"about_ca_system_score_codex":0.00024811155,"about_ca_system_score_gemma":0.00025918693,"threshold_uncertainty_score":0.012243807},"labels":[],"label_agreement":null},{"id":"W4249517047","doi":"10.13188/2376-922x.1000027","title":"Medical Driving Assessment Outcomes in Seniors Using The KSCAr+Drive: An In-Office Screening Tool to Assist Clinicians in Determining Driving Safety and Who to Refer for Medical Driving Assessments","year":2018,"lang":"en","type":"article","venue":"Journal of Parkinson’s Disease and Alzheimer’s Disease","topic":"Older Adults Driving Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Parkwood Institute; Providence Health Care; Queen's University","funders":"","keywords":"Medical assessment; Medicine; Occupational safety and health; Safe driving; Medical emergency; Engineering; Automotive engineering","score_opus":0.08268491123437534,"score_gpt":0.4782873265579258,"score_spread":0.39560241532355045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249517047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746776,0.000069618654,0.00009237726,0.00008518239,0.000014803666,0.000050163755,0.00064574805,0.000010255735,0.0015640592],"genre_scores_gemma":[0.99838865,0.00007558724,0.00043566016,0.000057539342,0.000020517675,0.000053524956,0.0006044244,0.0000021807077,0.00036187712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993938,0.00014103013,0.00013441105,0.00007439267,0.00015777299,0.000098574965],"domain_scores_gemma":[0.99729055,0.0004137513,0.0011744661,0.00007835604,0.00071836065,0.00032448914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013354695,0.00031212592,0.00035731043,0.0012563607,0.00039150432,0.00077546603,0.00024238438,0.0003491336,0.0012353779],"category_scores_gemma":[0.0053686993,0.00013557986,0.00049550575,0.0005920051,0.00014626661,0.0007976541,0.000651528,0.00045596022,0.00033426392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002390564,0.0002921334,0.98598284,0.000052815572,0.00004190294,0.00003398709,0.0003245256,0.000072827395,0.0001533284,0.000027901984,0.0005068289,0.012271848],"study_design_scores_gemma":[0.00001833329,0.00048834813,0.99796283,0.000027754739,0.000038898837,0.000086154636,0.00043900352,0.00031301662,0.00014569581,0.000031490184,0.00043981939,0.000008653478],"about_ca_topic_score_codex":0.008030471,"about_ca_topic_score_gemma":0.025337005,"teacher_disagreement_score":0.008030471,"about_ca_system_score_codex":0.00041272142,"about_ca_system_score_gemma":0.0006219848,"threshold_uncertainty_score":0.015967488},"labels":[],"label_agreement":null}]}